Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Cunningham

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Journal of the American Heart Association|December 3, 2025
Circulating Proteins Associated With Myocardial Interstitial FibrosisJonathan W Cunningham, Leonoor F J M Wijdeveld, Victor Nauffal, et al.
Clinical Cardiology|November 14, 2019
Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trialJonathan W Cunningham, Jie-Lena Sun, Finnian R Mc Causland, et al.
JMIR Medical Informatics|August 12, 2022
One Clinician Is All You Need-Cardiac Magnetic Resonance Imaging Measurement Extraction: Deep Learning Algorithm DevelopmentPulkit Singh, Julian Haimovich, Christopher Reeder, et al.
Lancet (London, England)|May 25, 2020
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trialsMuthiah Vaduganathan, Brian L Claggett, Pardeep S Jhund, et al.
JACC. Heart Failure|June 18, 2025
Effect of Neprilysin Inhibition on Plasma Proteins in Heart Failure With Mildly Reduced or Preserved Ejection FractionLuqing Zhang, Brian L Claggett, Pablo M Marti-Castellote, et al.
Gigascience|September 30, 2025
Foundation model of electronic medical records for adaptive risk estimationPawel Renc, Michal K Grzeszczyk, Nassim Oufattole, et al.
European Journal of Heart Failure|January 26, 2022
Natriuretic peptide-based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON-HFMaria A Pabón, Jonathan W Cunningham, Brian L Claggett, et al.
Journal of the American Heart Association|August 24, 2022
Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC StudyJenine E John, Brian Claggett, Hicham Skali, et al.
Journal of Cardiac Failure|December 19, 2024
Effectiveness of Virtual Care Team Guided Management of Hospitalized Patients with HFrEF by EthnicityJohn H Bertot, Anubodh S Varshney, Alea Moscone, et al.
JACC. Heart Failure|April 11, 2021
Worsening Heart Failure Episodes Outside a Hospital Setting in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF TrialMuthiah Vaduganathan, Jonathan W Cunningham, Brian L Claggett, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Journal of the American Heart Association|December 3, 2025
Circulating Proteins Associated With Myocardial Interstitial FibrosisJonathan W Cunningham, Leonoor F J M Wijdeveld, Victor Nauffal, et al.
Clinical Cardiology|November 14, 2019
Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trialJonathan W Cunningham, Jie-Lena Sun, Finnian R Mc Causland, et al.
JMIR Medical Informatics|August 12, 2022
One Clinician Is All You Need-Cardiac Magnetic Resonance Imaging Measurement Extraction: Deep Learning Algorithm DevelopmentPulkit Singh, Julian Haimovich, Christopher Reeder, et al.
Lancet (London, England)|May 25, 2020
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trialsMuthiah Vaduganathan, Brian L Claggett, Pardeep S Jhund, et al.
JACC. Heart Failure|June 18, 2025
Effect of Neprilysin Inhibition on Plasma Proteins in Heart Failure With Mildly Reduced or Preserved Ejection FractionLuqing Zhang, Brian L Claggett, Pablo M Marti-Castellote, et al.
Gigascience|September 30, 2025
Foundation model of electronic medical records for adaptive risk estimationPawel Renc, Michal K Grzeszczyk, Nassim Oufattole, et al.
European Journal of Heart Failure|January 26, 2022
Natriuretic peptide-based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON-HFMaria A Pabón, Jonathan W Cunningham, Brian L Claggett, et al.
Journal of the American Heart Association|August 24, 2022
Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC StudyJenine E John, Brian Claggett, Hicham Skali, et al.
Journal of Cardiac Failure|December 19, 2024
Effectiveness of Virtual Care Team Guided Management of Hospitalized Patients with HFrEF by EthnicityJohn H Bertot, Anubodh S Varshney, Alea Moscone, et al.
JACC. Heart Failure|April 11, 2021
Worsening Heart Failure Episodes Outside a Hospital Setting in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF TrialMuthiah Vaduganathan, Jonathan W Cunningham, Brian L Claggett, et al.
Pageof 8